Top View
- Xo PANEL DNA GENE LIST
- WO 2017/083562 Al 18 May 20 17 (18.05.2017) W P O P C T
- IDH1 and IDH2 Mutations
- Genetics MOLECULAR and HUMAN GENETICS 2021
- Ubiquitin Ligase Trim32 and Chloride-Sensitive WNK1 As Regulators of Potassium Channels in the Brain Eugene Miler Cilento University of Vermont
- Targeting the IDH2 Pathway in Acute Myeloid Leukemia Maria L
- D-2-Hydroxyglutarate Produced by Mutant IDH2 Causes Cardiomyopathy and Neurodegeneration in Mice
- Advances in New Targets for Differentiation Therapy of Acute Myeloid Leukemia
- SUPPLEMENTARY APPENDIX Exome Sequencing Reveals Heterogeneous Clonal Dynamics in Donor Cell Myeloid Neoplasms After Stem Cell Transplantation
- IDH1 and IDH2 Mutations in Myelodysplastic Syndromes and Role in Disease Progression
- Molecular Network-Based Identification of Competing Endogenous Rnas and Mrna Signatures That Predict Survival in Prostate Cancer
- Ectopic Expression of Cdk8 Induces Eccentric Hypertrophy and Heart Failure
- CDK9 Inhibitors in Acute Myeloid Leukemia Silvia Boffo1, Angela Damato1,2, Luigi Alfano3 and Antonio Giordano1,4*
- Genomic Profiling Identifies Association of IDH1/IDH2 Mutation
- Proteomic and Phosphoproteomic Profiling of Shammah Induced
- Autocrine IFN-I Inhibits Isocitrate Dehydrogenase in the TCA Cycle of LPS-Stimulated Macrophages
- List of Actionable Genes and Potential Matched Therapy
- APC/C-CDH1–Regulated Idh3b Coordinates with the Cell Cycle To
- DNMT3B Deficiency Alters Mitochondrial Biogenesis and Α-Ketoglutarate Levels in Human Embryonic Stem Cells
- IDH2 Gene Isocitrate Dehydrogenase (NADP(+)) 2, Mitochondrial
- Bioinformatics Approaches to Cancer Biomarker Discovery
- Isocitrate Dehydrogenase 2 Contributes to Radiation Resistance of Oesophageal Squamous Cell Carcinoma Via Regulating Mitochondrial Function and ROS/Pakt Signalling
- (12) Patent Application Publication (10) Pub. No.: US 2016/0053301 A1 RAYMOND Et Al
- Cancer-Associated IDH Mutations: Biomarker and Therapeutic Opportunities
- Navigating Through Mutations in Acute Myeloid Leukemia. What Do We Know and What Do We Do with It? INVITED REVIEW Deniz Peker
- Alleviation of Neuronal Energy Deficiency by Mtor Inhibition As A
- PI3K/AKT/Mtor Pathway Alterations Promote Malignant Progression
- Isocitrate Dehydrogenase Inhibitors in Acute Myeloid Leukemia Xiaoyan Liu and Yuping Gong*
- Screen for IDH1, IDH2, IDH3, D2HGDH and L2HGDH Mutations in Glioblastoma
- The PDK1/C‑Jun Pathway Activated by TGF‑Β Induces EMT and Promotes Proliferation and Invasion in Human Glioblastoma
- Wild-Type IDH Enzymes As Actionable Targets for Cancer Therapy
- Analysis of ALK, IDH1, IDH2 and MMP8 Somatic Mutations in Differentiated Thyroid Cancers
- Dynamics of ASXL1 Mutation and Other Associated Genetic Alterations During Disease Progression in Patients with Primary Myelodysplastic Syndrome
- IDH Mutations Occur Frequently in Chinese Glioma Patients and Predict Longer Survival but Not Response to Concomitant Chemoradiotherapy in Anaplastic Gliomas
- Highly Sensitive Detection of IDH2 Mutations in Acute Myeloid Leukemia
- Isocitrate Dehydrogenase Mutations Confer Dasatinib Hypersensitivity and SRC
- Evidence of Ambiguous Differentiation and Mtor Pathway Dysregulation
- Deciphering CXCR4 and ACKR3 Interactomes Reveals an Influence of ACKR3 Upon Gap Junctional Intercellular Communication Amos Fumagalli
- Phosphoproteomics Identifies Significant Biomarkers Associated with the Proliferation and Metastasis of Prostate Cancer
- Supplemental Table 6 RNA-Seq Simvastatin DEG FDR<0.05 2
- 2-Hydroxyglutarate Inhibits ATP Synthase and Mtor Signaling
- IDH2 Abbott Realtime PCR Diagnostic Test
- IDH1 and IDH2 Mutations in Therapy-Related Myelodysplastic Syndrome and Acute Myeloid Leukemia Are Associated with a Normal Karyotype and with Der(1;7)(Q10;P10)
- Isocitrate Dehydrogenase Mutations Confer Dasatinib Hypersensitivity and SRC Dependence in Intrahepatic Cholangiocarcinoma
- Isoform Switching As a Mechanism of Acquired Resistance to Mutant Isocitrate Dehydrogenase Inhibition
- Targeting Mtor and Glycolysis in HER2-Positive Breast Cancer
- Variable IPSS DIPSS DIPSS-Plus
- Podocyte-Specific Induction of Krüppel-Like Factor 15 Restores